4
Changes in Ownership
Beam Therapeutics Inc. Filed Acc 0000899243-23-002957
Chief Financial Officer sold 37,254 shares at an average $45.08 ($1,679,510)
- Chief Financial Officer acquired 37,254 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Burrell Terry-Ann Chief Financial Officer | 2023-01-26 | Option exercise | +1,102 | $13.68 | $15,075 | 32,379 | D |
| Burrell Terry-Ann Chief Financial Officer | 2023-01-26 | Sale | −1,102 | $45.16 | $49,763 | 31,277 | D |
| Burrell Terry-Ann Chief Financial Officer | 2023-01-27 | Option exercise | +36,152 | $13.68 | $494,559 | 67,429 | D |
| Burrell Terry-Ann Chief Financial Officer | 2023-01-27 | Sale | −36,152 | $45.08 | $1,629,747 | 31,277 | D |
| Derivatives | |||||||
| Burrell Terry-Ann Chief Financial Officer | 2023-01-26 | Option exercise · Stock Option (Right to Buy) | −1,102 | 221,717 | D | ||
| Burrell Terry-Ann Chief Financial Officer | 2023-01-27 | Option exercise · Stock Option (Right to Buy) | −36,152 | 185,565 | D | ||
| Open-market sales · 37,254 sh · avg $45.08 · $1,679,510 | |||||||
Loading xslF345X03/doc4.xml…